Phenological discrimination for four LACIE test sights

There are no author-identified significant results in this report

Molecular evidence for the clonal origin of blast crisis in chronic myeloid leukaemia.

Cytogenetic and enzymatic studies have shown that chronic myeloid leukemia (CML) represents the clonal proliferation of a pluripotent stem cell. The Philadelphia chromosome (Ph') is the characteristic karyotypic abnormality seen in this disease, although the exact role of this clonal marker in the pathogenesis of CML is uncertain. At a molecular level, the Ph' has recently been shown to represent the translocation of c-abl to a limited (breakpoint cluster region, bcr) on chromosome 22. We have used probes for the bcr gene to obtain molecular evidence for the clonal origin of blast crisis in 2 patient with CML. In both cases, the first with myeloid and the second with lymphoid blast crisis, there was rearrangement of the bcr gene. The patterns of rearrangement varied between patients but were identical when comparing acute and chronic phases within the same individual. As the Ph' translocation is thought to represent a random recombination event these data not only provide further evidence for the clonal origin of blast crisis in CML, but also suggest that in the second patient this translocation event had already occurred at the pluripotent stem cell

Information extraction and transmission techniques for spaceborne synthetic aperture radar images

Information extraction and transmission techniques for synthetic aperture radar (SAR) imagery were investigated. Four interrelated problems were addressed. An optimal tonal SAR image classification algorithm was developed and evaluated. A data compression technique was developed for SAR imagery which is simple and provides a 5:1 compression with acceptable image quality. An optimal textural edge detector was developed. Several SAR image enhancement algorithms have been proposed. The effectiveness of each algorithm was compared quantitatively

General Information and Biographical Data - Technical Session, Education and Personnel October 7, 1964, Miami, Florida.

https://egrove.olemiss.edu/aicpa_assoc/2283/thumbnail.jp

Composing protocol frameworks for active wireless networks

This article describes a new model for a composible protocol framework that is suitable for the rapid development of any application-specific service and its deployment in the network. The class-hierarchy model described here enables users to compose their own custom, flexible frameworks from either predefined or custom protocol components tailored to an application's needs. We validate experimentally that application-specific frameworks implementing custom protocols can be developed to improve performance of applications over wireless networks.©2000 IEEE. Personal use of this material is permitted. However, permission to reprint/republish this material for advertising or promotional purposes or for creating new collective works for resale or redistribution to servers or lists, or to reuse any copyrighted component of this work in other works must be obtained from the IEEE

Population adaptation for genetic algorithm-based cognitive radios

Abstract — Genetic algorithms are best suited for optimization problems involving large search spaces. The problem space encountered when optimizing the transmission parameters of an agile or cognitive radio for a given wireless environment and set of performance objectives can become prohibitively large due to the high number of parameters and their many possible values. Recent research has demonstrated that genetic algorithms are a viable implementation technique for cognitive radio engines. However, the time required for the genetic algorithms to come to a solution substantionally increases as the system complexity grows. In this paper, we present a population adaptation technique for genetic algorithms that takes advantage of the information from previous cognition cycles in order to reduce the time required to reach an optimal decision. Our simulation results demonstrate that the amount of information from the previous cognition cycle can be determined from the environmental variation factor (EVF), which represents the amount of change in the environment parameters since the previous cognition cycle. I

The serine/threonine kinase PAK4 prevents caspase activation and protects cells from apoptosis

The serine/threonine kinase PAK4 was identified first as an effector molecule for the Rho GTPase Cdc42. PAK4 differs from other members of the PAK family both in sequence and function. Previously we have shown that an important function of this kinase is to mediate the induction of filopodia in response to activated Cdc42. Studies with a, constitutively active PAK4 mutant have shown that it also has a role in promoting anchorage-independent growth, an important hallmark of oncogenic transformation. Here we show that another function of PAK4 is to protect cells against apoptotic cell death. Expression of wild-type or constitutively active PAK4 delays the onset of apoptosis in response to tumor necrosis factor LY stimulation, UV irradiation, and serum starvation. Consistent with an antiapoptotic function, expression of PAK4 leads to an increase in phosphorylation of the proapoptotic protein Bad and an inhibition of caspase activation

Budget Statements for Council Consideration, October 1964

https://egrove.olemiss.edu/aicpa_assoc/2290/thumbnail.jp

A Phase 1 study of intravenous infusions of tigecycline in patients with acute myeloid leukemia.

Acute myeloid leukemia (AML) cells meet the higher energy, metabolic, and signaling demands of the cell by increasing mitochondrial biogenesis and mitochondrial protein translation. Blocking mitochondrial protein synthesis through genetic and chemical approaches kills human AML cells at all stages of development in vitro and in vivo. Tigecycline is an antimicrobial that we found inhibits mitochondrial protein synthesis in AML cells. Therefore, we conducted a phase 1 dose-escalation study of tigecycline administered intravenously daily 5 of 7 days for 2 weeks to patients with AML. A total of 27 adult patients with relapsed and refractory AML were enrolled in this study with 42 cycles being administered over seven dose levels (50-350 mg/day). Two patients experienced DLTs related to tigecycline at the 350 mg/day level resulting in a maximal tolerated dose of tigecycline of 300 mg as a once daily infusion. Pharmacokinetic experiments showed that tigecycline had a markedly shorter half-life in these patients than reported for noncancer patients. No significant pharmacodynamic changes or clinical responses were observed. Thus, we have defined the safety of once daily tigecycline in patients with refractory AML. Future studies should focus on schedules of the drug that permit more sustained target inhibition